Additional information
| Active substance | Temozolomide |
|---|---|
| Water Retention | No significant impact |
| Hepatotoxicity | Low |
| Lab Test | CBC (Complete Blood Count) monitoring |
| Strength | 100mg |
| Also known as | TMZ, Methazolastone |
| Blood pressure | No direct effect |
| Trade name | Temodar, Temodal, Temcad |
| Storage conditions | Store at controlled room temperature, 20-25В°C (68-77В°F) |
| Chemical name | 3,4-Dihydro-3-methyl-4-oxoimidazo[5,1-d]-1,2,3,5-tetrazine-8-carboxamide |
| Formula | C6H6N6O2 |
| Substance class | Alkylating agent |
| Main action | Antineoplastic |
| Half-life | 1.8 hours |
| Dosage (medical) | Typically 150-200 mg/mВІ per day for 5 days every 28 days cycle |
| Dosage (sports) | Not applicable |
| Effects | Antitumor effect, crosses the blood-brain barrier |
| Side effects | Nausea, vomiting, constipation, loss of appetite, alopecia, headache, fatigue, neutropenia, thrombocytopenia |
| Use in sports | None |
| Manufacturer | Cipla Ltd. |
| Packing | 5 caps/bottle |
Rovamycine 3.000.000 iu Eczacibasi
BIOSYNERGY RECOVERY3 PEPTIDE BLEND LIFETECH LABS
DELETE - Micardis 80 mg Boehringer Ingelheim
FUCIDIN 500 mg Abdi Ibragim
Fostimon (Merional) 150 IU HMG IBSA
Tretiva 10 mg Intas Pharmaceuticals
Seretide Disckus (Advair) 250 mcg Glaxosmithkline 

Reviews
There are no reviews yet.